In this work, an electrochemiluminescent (ECL) biosensor was constructed on the basis of amino-modified 3,4,9,10-perylenetetracarboxylic dianhydride/luminol (PTC-NH 2 /Lu) nanocomposite as emitter and bipedal DNA walker signal amplification strategy for ultrasensitive detection of microRNA-21 (miRNA-21). The PTC-NH 2 /Lu nanocomposite was prepared as signal tag via π−π stacking molecular assembly, in which amino-modified 3,4,9,10-perylenetetracarboxylic dianhydride (PTC-NH 2 ) as a novel coreaction accelerator significantly enhanced the ECL emission of luminol-H 2 O 2 system. Moreover, target miRNA-21 triggered bipedal DNA walker was powered by toehold-mediated strand displacement reaction (TSDR) for signal amplification. Consequently, the proposed ECL biosensor achieved ultrasensitive detection of miRNA-21 with a linear range from 100 aM to 100 pM and a limit of detection of 33 aM. Simultaneously, the biosensor was also successfully applied to detect target miRNA-21 in lysates from human cancer cells. As a result, this work constructed a new signal amplification platform, exhibiting great application potential in biomedical analysis and early clinical diagnostics.
Sepsis is a life-threatening syndrome caused by a dysregulated host response to infection. 1,2 Sepsis most commonly results in multiorgan dysfunction, especially kidney dysfunction, namely sepsis-associated acute kidney injury (SA-AKI). It constitutes almost 50% of cases diagnosed with acute kidney injury in intensive care units (ICU). 3-7 Furthermore, SA-AKI increases the risk of chronic kidney disease and is a leading independent cause of high mortality. 2 Unlike any other phenotype of acute kidney injury (AKI), SA-AKI
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.